Mounjaro is a medication approved for the treatment of type 2 diabetes in adults
GLP-1 agonists work by binding to GLP-1 receptors in various tissues, including the pancreas, brain, and gastrointestinal tract
These medications target the GLP-1 receptor to suppress appetite and increase feelings of fullness, fostering enduring weight loss
The entire procedure was carried out on ice to preserve protein activity and stability
Lead Diabetes Care Primary Care Support Metabolic Health Preventive Care Urgent Visit Care Learn how Tirzepatide and Semaglutide work, what makes them different, and why patients use them as part of a medically supervised weight loss plan
We pair science with coaching, coverage, and community so you feel supported every step of the way